Annual D&A:
$5.46M+$195.00K(+3.70%)Summary
- As of today, RLAY annual D&A is $5.46 million, with the most recent change of +$195.00 thousand (+3.70%) on December 31, 2024.
- During the last 3 years, RLAY annual D&A has risen by +$1.54 million (+39.21%).
- RLAY annual D&A is now at all-time high.
Performance
RLAY Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$748.00K-$254.00K(-25.35%)Summary
- As of today, RLAY quarterly D&A is $748.00 thousand, with the most recent change of -$254.00 thousand (-25.35%) on September 30, 2025.
- Over the past year, RLAY quarterly D&A has dropped by -$619.00 thousand (-45.28%).
- RLAY quarterly D&A is now -46.38% below its all-time high of $1.40 million, reached on March 31, 2024.
Performance
RLAY Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$4.29M-$619.00K(-12.60%)Summary
- As of today, RLAY TTM D&A is $4.29 million, with the most recent change of -$619.00 thousand (-12.60%) on September 30, 2025.
- Over the past year, RLAY TTM D&A has dropped by -$1.21 million (-22.03%).
- RLAY TTM D&A is now -22.03% below its all-time high of $5.50 million, reached on September 30, 2024.
Performance
RLAY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RLAY Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +3.7% | -45.3% | -22.0% |
| 3Y3 Years | +39.2% | -27.6% | +7.3% |
| 5Y5 Years | +92.1% | -18.1% | +23.0% |
RLAY Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +39.2% | -46.4% | at low | -22.0% | +7.3% |
| 5Y | 5-Year | at high | +92.1% | -46.4% | at low | -22.0% | +23.0% |
| All-Time | All-Time | at high | +153.7% | -46.4% | +18.0% | -22.0% | +543.5% |
RLAY Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $748.00K(-25.3%) | $4.29M(-12.6%) |
| Jun 2025 | - | $1.00M(-17.1%) | $4.91M(-6.9%) |
| Mar 2025 | - | $1.21M(-9.4%) | $5.28M(-3.4%) |
| Dec 2024 | $5.46M(+3.7%) | $1.33M(-2.4%) | $5.46M(-0.7%) |
| Sep 2024 | - | $1.37M(-0.1%) | $5.50M(+0.1%) |
| Jun 2024 | - | $1.37M(-1.9%) | $5.50M(+0.6%) |
| Mar 2024 | - | $1.40M(+1.5%) | $5.47M(+3.8%) |
| Dec 2023 | $5.27M(+27.6%) | $1.38M(+0.9%) | $5.27M(+4.1%) |
| Sep 2023 | - | $1.36M(+2.2%) | $5.06M(+7.0%) |
| Jun 2023 | - | $1.33M(+11.4%) | $4.73M(+8.7%) |
| Mar 2023 | - | $1.20M(+2.7%) | $4.35M(+5.4%) |
| Dec 2022 | $4.13M | $1.17M(+12.9%) | $4.13M(+3.3%) |
| Sep 2022 | - | $1.03M(+8.1%) | $4.00M(+0.5%) |
| Jun 2022 | - | $956.00K(-1.9%) | $3.98M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $975.00K(-5.7%) | $3.98M(+1.4%) |
| Dec 2021 | $3.92M(+10.6%) | $1.03M(+2.2%) | $3.92M(+3.2%) |
| Sep 2021 | - | $1.01M(+5.4%) | $3.80M(+2.7%) |
| Jun 2021 | - | $960.00K(+4.5%) | $3.70M(+2.6%) |
| Mar 2021 | - | $919.00K(+0.8%) | $3.61M(+1.7%) |
| Dec 2020 | $3.55M(+24.7%) | $912.00K(-0.1%) | $3.55M(+1.7%) |
| Sep 2020 | - | $913.00K(+5.5%) | $3.49M(+8.7%) |
| Jun 2020 | - | $865.00K(+0.7%) | $3.21M(+5.7%) |
| Mar 2020 | - | $859.00K(+0.7%) | $3.04M(+6.7%) |
| Dec 2019 | $2.85M(+32.1%) | $853.00K(+34.5%) | $2.85M(+42.8%) |
| Sep 2019 | - | $634.00K(-8.2%) | $1.99M(+46.7%) |
| Jun 2019 | - | $691.00K(+3.6%) | $1.36M(+103.6%) |
| Mar 2019 | - | $667.00K | $667.00K |
| Dec 2018 | $2.15M | - | - |
FAQ
- What is Relay Therapeutics, Inc. annual D&A?
- What is the all-time high annual D&A for Relay Therapeutics, Inc.?
- What is Relay Therapeutics, Inc. annual D&A year-on-year change?
- What is Relay Therapeutics, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Relay Therapeutics, Inc.?
- What is Relay Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Relay Therapeutics, Inc. TTM D&A?
- What is the all-time high TTM D&A for Relay Therapeutics, Inc.?
- What is Relay Therapeutics, Inc. TTM D&A year-on-year change?
What is Relay Therapeutics, Inc. annual D&A?
The current annual D&A of RLAY is $5.46M
What is the all-time high annual D&A for Relay Therapeutics, Inc.?
Relay Therapeutics, Inc. all-time high annual D&A is $5.46M
What is Relay Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, RLAY annual D&A has changed by +$195.00K (+3.70%)
What is Relay Therapeutics, Inc. quarterly D&A?
The current quarterly D&A of RLAY is $748.00K
What is the all-time high quarterly D&A for Relay Therapeutics, Inc.?
Relay Therapeutics, Inc. all-time high quarterly D&A is $1.40M
What is Relay Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, RLAY quarterly D&A has changed by -$619.00K (-45.28%)
What is Relay Therapeutics, Inc. TTM D&A?
The current TTM D&A of RLAY is $4.29M
What is the all-time high TTM D&A for Relay Therapeutics, Inc.?
Relay Therapeutics, Inc. all-time high TTM D&A is $5.50M
What is Relay Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, RLAY TTM D&A has changed by -$1.21M (-22.03%)